Clinical Scorecard: Low PET uptake may mask aortic sarcoma
At a Glance
Category
Detail
Condition
Aortic intimal sarcoma with myxoid features
Key Mechanisms
Myxoid tumor composition may be associated with low FDG-PET uptake; tumor embolization can cause arterial occlusions and organ infarctions.
Target Population
Patients with an intraluminal aortic mass and embolic complications, as described in a single-patient case report.
Care Setting
Diagnostic evaluation and surgical management of an aortic mass, including imaging, pathology, and molecular testing.
Key Highlights
In the reported case, FDG-PET showed minimal uptake (maximum standardized uptake value 3.1), favoring thrombus over malignancy.
The patient experienced recurrent arterial embolization despite anticoagulant therapy.
The gelatinous mass resembled a benign myxoma intraoperatively, and frozen section supported that preliminary diagnosis.
Definitive pathology identified myxoid intimal sarcoma; immunohistochemistry was positive for MDM2, CDK4, and FLI-1, and FISH confirmed MDM2 amplification.
The patient died 159 days after surgery; the single-case report cannot establish whether earlier diagnosis or additional treatment would have changed the outcome.
Guideline-Based Recommendations
Diagnosis
The authors advise maintaining suspicion for malignancy in aortic masses with embolic complications, even when imaging appears benign.
Definitive diagnosis in this case followed surgical resection and pathologic examination. The proposed diagnostic approach, including MDM2/CDK4 immunohistochemistry and molecular testing in suspicious aortic masses, requires validation in larger case series.
Management
Monitoring & Follow-up
Risks
Patient & Prescribing Data
A 69-year-old man with an aortic intraluminal mass, renal and splenic embolic infarctions, and subsequent left popliteal artery occlusion.
After recurrent embolization, the patient underwent en bloc resection and aortic graft replacement. Anthracycline-based adjuvant chemotherapy was recommended but declined; he died 159 days after surgery.
Clinical Best Practices
Consider malignancy in an aortic mass associated with recurrent embolic events, even when FDG-PET uptake is low or the lesion appears benign.
Interpret imaging and intraoperative appearance alongside definitive histopathology; the reported case showed discordance among these assessments.
Recognize that the proposed use of MDM2/CDK4 immunohistochemistry and molecular testing in suspicious aortic masses requires validation in larger case series.
Shear wave velocity measurements in the basal anteroseptal and right ventricular walls differed between transthyretin and light chain cardiac amyloidosis when conventional echocardiographic parameters did not.
Baptist Health South Florida will host the Baptist Health Heart & Vascular Care 43rd Annual Echocardiography and Structural Heart Symposium on Oct. 2-3 at the Loews Coral Gables Hotel.
